UroGen Pharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $24,215 | $20,254 | $24,565 | $25,204 |
Gross Profit | 20,665 | 17,924 | 22,094 | 22,751 |
EBITDA | -41,448 | -36,914 | -24,602 | -14,680 |
EBIT | -37,411 | -24,908 | -14,946 | |
Net Income | -49,940 | -43,843 | -37,512 | -23,673 |
Net Change In Cash | 24,215 | 20,254 | 24,565 | 25,204 |
Free Cash Flow | -39,966 | -42,068 | -13,734 | -27,760 |
Cash | 92,904 | 104,033 | 171,987 | 124,916 |
Basic Shares | 47,739 | 47,422 | 47,030 | 43,100 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $90,398 | $82,713 | $64,357 | $48,042 |
Gross Profit | 81,517 | 73,352 | 56,703 | 42,885 |
EBITDA | -110,335 | -60,352 | -76,214 | -90,154 |
EBIT | -111,521 | -62,057 | -78,031 | -91,927 |
Net Income | -126,874 | -102,244 | -109,783 | -110,820 |
Net Change In Cash | 90,398 | 82,713 | 64,357 | 48,042 |
Cost of Revenue | 10,635 | -8,504 | ||
Free Cash Flow | -97,061 | -76,570 | -87,813 | -85,644 |
Cash | 171,987 | 95,002 | 55,408 | 44,360 |
Basic Shares | 42,876 | 28,834 | 22,806 | 22,347 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$1.05 |
2025-03-31 | -$0.92 |
2024-12-31 | -$0.80 |
